On December 10, 2021, America Great Health (the “Company”) entered into an Advisory Committee Member Consulting Agreement with Iden Michael Borkin (the “Consultant”). Pursuant to the Agreement, Consultant is to provide advisory services, as a member to the Advisory Committee to the Board of Directors of the Company, including without limitation, assisting the Company in finding and hiring expert consultants familiar with the U.S. Food and Drug Administration.
America Great Health (OTC: AAGH) entered into an Advisory Committee Member Consulting Agreement with Iden Michael Borkin
Earlier from America Great Health
- America Great Health (OTC: AAGH) entered into an Advisory Committee Member Consulting Agreement with Dr. Kevin Buckman MD.
- America Great Health (OTC: AAGH) entered into a Supplemental Assets Acquisition Agreement with Wang’s Property Investment & Management LLC
- America Great Health (OTC: AAGH) entered into a Cooperation Agreement with Dr.David Tsai, a pioneer in anti-cancer peptide research and invention in the United States
- America Great Health (OTC: AAGH) completed the acquisition of 51% equity in Purecell Group
